Immatics Nv Stock Investor Sentiment

IMTX Stock  USD 7.18  0.09  1.24%   
Slightly above 62% of Immatics' investor base is looking to short. The analysis of the overall investor sentiment regarding Immatics NV suggests that many traders are alarmed. Immatics' investing sentiment can be driven by a variety of factors including economic data, Immatics' earnings reports, geopolitical events, and overall market trends.
  

Immatics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Immatics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at investorplace.com         
IMTX Stock Earnings Immatics Beats EPS, Beats Revenue for Q2 2024
sbwire news
over three months ago at zacks.com         
Iovance Q2 Earnings Beat, Stock Up on Upbeat Sales View
zacks News
over three months ago at zacks.com         
Insmed Lags on Q2 Earnings, Tops Sales, Reiterates View
zacks News
over three months ago at zacks.com         
Arcus Biosciences, Inc. Reports Q2 Loss, Tops Revenue Estimates
zacks News
over three months ago at zacks.com         
Perrigo Beats on Q2 Earnings, Lags Sales, Cuts View
zacks News
over three months ago at zacks.com         
JAZZ Tops Q2 Earnings Sales Estimates, Revises 24 View
zacks News
over three months ago at benzinga.com         
United Therapeutics Q2 Earnings Lag, Sales Top Estimates
benzinga news
over three months ago at finance.yahoo.com         
Investors in Immatics have seen returns of 24 percent over the past five years
Yahoo News
over three months ago at zacks.com         
Heres Why Trend Investors Would Love Betting on Immatics
zacks News
over three months ago at zacks.com         
Wall Street Analysts Predict a 54.95 percent Upside in Immatics Heres What You Should Know
zacks News
over three months ago at benzinga.com         
Heres Why Trend Investors Would Love Betting on Immatics
benzinga news
over three months ago at news.google.com         
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024 - StockTitan
Google News at Macroaxis
over three months ago at simplywall.st         
Immatics Is In A Good Position To Deliver On Growth Plans
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
Immatics to Post FY2024 Earnings of Per Share, Chardan Capital Forecasts - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Wasatch Advisors LP Makes New Investment in Immatics - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Immatics that are available to investors today. That information is available publicly through Immatics media outlets and privately through word of mouth or via Immatics internal channels. However, regardless of the origin, that massive amount of Immatics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immatics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immatics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immatics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immatics alpha.

Immatics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Immatics stock falls as it looks to raise 150M via public offering
10/10/2024
2
Immatics Announces Pricing of 150 Million Public Offering
10/11/2024
3
Immatics Sees Significant Decrease in Short Interest
10/16/2024
4
Immatics Short Interest Update
10/31/2024
5
Analysts Estimate Avidity Biosciences, Inc. to Report a Decline in Earnings What to Look Out for
11/06/2024
6
Immatics Announces Third Quarter 2024 Financial Results, Busines
11/18/2024
7
Bank of America Cuts Immatics Price Target to 15.00
11/19/2024
8
Immatics FY2024 EPS Forecast Increased by Leerink Partnrs
11/21/2024

Additional Tools for Immatics Stock Analysis

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.